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Geographic Miss
A Cause of Treatment Failure in Radio-Oncology Applied to
Intracoronary Radiation Therapy
Manel Sabate´, MD; Marco A. Costa, MD; Ken Kozuma, MD; I. Patrick Kay, MBChB;
Willem J. van der Giessen, MD, PhD; Veronique L.M.A. Coen, MD; Jurgen M.R. Ligthart, BSc;
Pedro Serrano, MD; Peter C. Levendag, MD, PhD; Patrick W. Serruys, MD, PhD
Background—A recognized limitation of endovascular b-radiation therapy is the development of new stenosis at the edges
of the irradiated area. The combination of injury and low-dose radiation may be the precursor of this phenomenon. We
translated the radio-oncological concept of “geographic miss” to define cases in which the radiation source did not fully
cover the injured area. The aims of the study were to determine the incidence and causes of geographic miss and evaluate
the impact of this inadequate treatment on the outcome of patients treated with intracoronary b-radiation.
Methods and Results—We analyzed 50 consecutive patients treated with b-radiation after percutaneous coronary
intervention. The prescribed dose ranged between 12 and 20 Gy at 2 mm from the source axis. By means of quantitative
coronary angiography, the irradiated segment (IRS) and both edges were studied before and after intervention and at
6-month follow-up. Edges that were injured during the procedure constituted the geographic miss edges. Twenty-two
edges were injured during the intervention, mainly because of procedural complications that extended the treatment
beyond the margins of the IRS. Late loss was significantly higher in geographic miss edges than in IRSs and uninjured
edges (0.8460.6 versus 0.1560.4 and 0.0960.4 mm, respectively; P,0.0001). Similarly, restenosis rate was
significantly higher in the injured edges (10% within IRS, 40.9% in geographic miss edges, and 1.9% in uninjured edges;
P,0.001).
Conclusions—These data support the hypothesis that the combination of injury and low-dose b-radiation induces
deleterious outcome. (Circulation. 2000;101:2467-2471.)
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Endovascular radiation therapy is a novel technique aimedat preventing restenosis after percutaneous coronary
intervention.1–3 Radiation can be delivered to the coronary
artery by means of catheter-based systems or radioactive
stents.4 A potential drawback of this treatment is the devel-
opment of new stenotic lesions at both edges of the irradiated
segment (IRS). This so-called “edge effect” was originally
described after high-activity (.3 mCi) radioactive stent
implantation.5,6 However, this phenomenon is not exclusive
to radioactive stents and may also affect coronary segments
treated by means of catheter-based systems.7 The pathophys-
iology of the edge effect may be the result of vessel wall
injury8–10 concomitant with low-dose radiation at the edges of
the irradiated area.11,12 In radio-oncology, the term to define
a cause of treatment failure due to low dose was coined by the
Manchester Clinic as “geographic miss.” In such cases, a
small part of the treatment zone has either escaped radiation
or been inadequately irradiated because the total volume of
the tumor was not appreciated and hence an insufficient
margin was taken.13 This concept is translated in interven-
tional cardiology to define those coronary segments that were
injured but received low-dose radiation. Typically, this phe-
nomenon occurs when the edges of the IRS, where, by
definition, the dose is rather low, are injured.
The aims of the study were (1) to determine the incidence
and causes of geographic miss in the treatment of patients
with intracoronary b-radiation by use of a catheter-based
system and (2) to evaluate the impact of this inadequate
treatment on the angiographic outcome of these patients.
Methods
Patient Selection
We retrospectively analyzed 50 consecutive patients treated at our
institution with catheter-based b-radiation by means of the Beta-Cath
system (Novoste Corp). Patients included in the radiation protocol
were those with objective signs of ischemia and presence of
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significant de novo lesions (n539) or recurrent in-stent restenosis
(n511). A detailed description of the radiation system has been
reported elsewhere.14 The radiation source train consists of a series
of 12 cylindrical seeds that contain the radioisotope 90Sr/90Y sources
and is bordered by 2 gold radiopaque markers separated by 30 mm.14
Procedure
The medical ethics committee of our institution approved the
investigational use of b-radiation, and all patients signed an in-
formed consent form. Percutaneous intervention was performed
according to standard clinical practice. Typically, coronary lesions
were treated initially with balloon angioplasty (BA). After successful
BA, the target coronary segment was irradiated. This could be
followed by additional stent implantation when clinically indicated.
Lesion length measured on average 11.464 mm, the mean balloon
length was 20.063 mm, and the number of balloon inflations was
2.961.6. Patients received aspirin (250 mg) and heparin (10 000 IU
IV) at the initiation of the procedure, and an additional dose of
heparin was administered to maintain the activated clotting time
.300 seconds. After the procedure, aspirin was continued indefi-
nitely. In patients who also received stent implantation, ticlopidine
was initiated and continued for $15 days after the procedure. The
radiation dose was prescribed at 2 mm from the source axis. The
prescribed dose for the treatment of de novo lesions was randomly
assigned to 12, 14, or 16 Gy for protocol requirements. For the
treatment of in-stent restenotic lesions, the prescribed dose was 16 or
20 Gy if the reference diameter, by quantitative coronary angiogra-
phy (QCA), measured #3.25 mm or .3.25 mm, respectively. The
mean dwell time to deliver these doses was 143644 seconds.
Definitions
The IRS was defined as the area encompassed by the 2 gold markers
of the radiation source train. It was identified on angiography by a
contrast injection with the source in place. The edges of the IRS were
defined as the 5-mm-long segments proximal and distal to the
angiographic location of the gold markers. The edges that were
touched by the angioplasty balloon or received new stent implanta-
tion during the procedure were defined as geographic miss edges,
because they represent injured segments receiving low-dose radia-
tion. Uninjured edges were those that were not traumatized during
the intervention. To determine whether the edges of the IRS were
injured, a few steps were followed: during the procedure, every
balloon inflation or additional stent implantation was filmed in the
same projection, as was the radiation source. This approach allowed
us the correct matching of the cine films in the offline analysis.
Either cine loop showing balloon inflation, stent implantation, and
radiation source may be displayed simultaneously on the screen with
the Rubo DICOM Viewer (Rubo Medical Imaging). ECG tracing is
also displayed in either cine loop. By selecting those frames in the
same part of the cardiac cycle, we were able to define the location of
the radiation source relative to the injured area.
QCA Analysis
The IRS and both edges were analyzed by QCA before and after
intervention and at 6-month follow-up. All angiograms were evalu-
ated after intracoronary administration of nitrates. The offline anal-
ysis of 2 orthogonal projections was performed by means of the
CAAS II analysis system (Pie Medical BV). Calibration of the
system was based on dimensions of the catheters not filled with
contrast medium. This method of analysis has been previously
validated.15–17 The following QCA parameters were computed in the
IRS and both edges: minimal luminal diameter (MLD), which was
computer defined; reference diameter, which was obtained by an
interpolated method15–17; and percentage diameter stenosis. Binary
restenosis was defined in every area as diameter stenosis .50% at
follow-up. Acute gain was defined as MLD after treatment minus
MLD before intervention. Late loss was defined as MLD after
treatment minus MLD at follow-up. Relative late loss was defined as
late loss divided by reference diameter.18
Statistical Analysis
To compare continuous variables between IRS, geographic miss
edges, and uninjured edges, 1-way ANOVA with post hoc analysis
for multiple comparisons was performed. Unpaired Student’s t test
was performed to compare continuous variables between proximal
and distal geographic miss edges and between patients in whom the
geographic miss was induced by balloon dilatation or stent implan-
tation. To compare the binary restenosis between groups, the x2 test
was performed. All tests were 2-tailed, and a value of P,0.05 was
considered statistically significant.
Results
Baseline Characteristics
Fifty irradiated coronary arteries and 100 edges in 50 patients
were eligible for the study. However, 26 edges were excluded
because of the ostial location of the proximal end of the
source in the right coronary artery (n512) or overlapping of
1 of the edges with side branches (n514). Thus, finally, 74
edge areas and 50 IRSs were studied. Mean age was 55.369
years, and 38 patients (76%) were male. Smoking was the
most frequent coronary risk factor, involving 33 patients
(66%), followed by dyslipidemia in 27 patients (54%) and
hypertension in 24 patients (48%). Eight patients (16%) were
diabetic. The left anterior descending coronary artery was
treated in 21 patients, the left circumflex in 10, the right
coronary artery in 18, and a saphenous vein graft in 1. Twelve
patients received a stent in a bailout situation.
Incidence and Causes of Geographic Miss
Geographic miss was observed in 22 edges (31.9%) induced
by balloon dilatation (n513) or additional stent implantation
(n59). The remaining 51 edges (68.9%) were defined as
uninjured edges. The location of the geographic miss was in
the proximal edge in 11 patients (50%) and in the distal
margin in 11 patients (50%). The following reasons were
responsible for this phenomenon: (1) development of proce-
dural complications that extended the treatment beyond the
margins of the IRS (unexpected geographic miss, n59); (2)
lack of availability of a longer radiation source (.30 mm) in
patients with diffuse recurrent in-stent restenosis in whom
radiation was given on a compassionate-use basis (n58); and
(3) lack of accurate matching; ie, the injured segment from
previous balloon inflations was not appropriately covered by
the source (n55). An example of a patient with geographic
miss induced by a balloon dilatation in the proximal margin
is depicted in Figure 1.
QCA Analysis
QCA data are presented in the Table. As expected, IRSs
demonstrated, on average, a higher acute gain than both
injured and uninjured edges. However, geographic miss
edges presented, on average, with significantly higher late
loss and relative late loss. Restenosis was demonstrated in 5
cases (10%) within the IRS, in 9 cases (40.9%) in the
geographic miss edges, and in 1 case (1.9%) in the uninjured
edges (P,0.001). No difference in the pattern of the late loss
between the 3 areas was observed in de novo lesions
compared with recurrent in-stent restenotic lesions (Figure 2).
In the geographic miss edges, 4 edge restenoses (44%) were
located at the proximal edges, whereas the other 5 (56%)
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were located at the distal edges. Mean relative late loss was
comparable between those edges, with geographic miss
located proximal or distal to the IRS (0.3160.2 versus
0.3460.2, respectively; P5NS). Those edges in which the
geographic miss was due to additional stent implantation
presented, on average, higher acute gain than those due to
balloon dilatation (0.7060.4 versus 0.2160.3, respectively;
P50.005). However, mean late loss and mean relative late
loss were comparable between both causes of geographic
miss (0.9560.9 mm and 0.3660.3, respectively, after stent
versus 0.7760.3 mm and 0.3060.1 after balloon dilatation;
both P5NS).
Discussion
This study reports on the initial experience of our center with
the use of intracoronary b-radiation. By means of a careful
retrospective angiographic analysis of all patients treated with
the same radiation system, we sought to define the effect of
the injury on those areas located at the margins of the source
where the delivered dose is potentially rather low. Up to
31.9% of the patients presented with the predefined technical
error, called geographic miss. This concept requires the
concurrence of 2 conditions: low-dose radiation and injury.
Any other clinical situations that do not include both condi-
tions cannot be called geographic miss. For instance, (1) the
effect of injury on coronary segments not being irradiated
(proximal or distal to an IRS but in areas in which the
calculated dose is almost 0) should fall into the category of
normal restenotic process; (2) the effect of low-dose radiation
in areas that have not been injured may be defined as the pure
radiation edge effect, because in intracoronary radiation, the
Figure 1. Geographic miss induced by
balloon dilatation. A, Lesion located in
proximal segment of left anterior
descending coronary artery. B, Balloon
dilatation performed during intervention
(black arrowheads indicate area injured by
balloon). C, Radiation source train in
place. Irradiated area is delimited by gold
markers (white arrowheads). D, Final
result: proximal traumatized edge present-
ed a residual type B dissection. E, At
6-month follow-up: obvious reduction in
lumen at geographic miss edge.
QCA Data
IRS
(n550)
Geographic Miss
Edges (n522)
Uninjured Edges
(n552) P
MLD before intervention, mm 1.2060.3 2.0260.6 2.1060.6 ,0.0001
MLD after intervention, mm 2.0260.4 2.4360.5 2.1260.6 0.01
MLD at follow-up, mm 1.8760.5 1.5960.6 2.0260.5 0.006
Reference diameter, mm 2.6960.6 2.5060.6 2.5560.7 NS
%DS before intervention, % 54.9613 19.8614 17.9611 ,0.0001
%DS after intervention, % 28.469 19.9610 20.8611 0.0003
%DS at follow-up, % 33.3611 44.3622 24.3610 ,0.0001
Acute gain, mm 0.8160.4 0.4160.4 0.0160.3 ,0.0001
Late loss, mm 0.1560.4 0.8460.6 0.0960.4 ,0.0001
Relative late loss 0.0660.1 0.3260.2 0.0260.1 ,0.0001
%DS indicates diameter stenosis. Data are mean6SD.
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edges of any IRS will always receive low-dose radiation; and
(3) finally, the effect of a full prescribed dose on segments
presenting with or without injury is the situation in which the
physician may be able to irradiate (with full dose) the entire
injured segment and include some uninjured margin. A key
issue in the definition of geographic miss is to define those
segments receiving a low dose. These may vary between
systems and sources used. With the Beta-Cath system, the
longitudinal distance of the 100% isodose is 26 mm. Because
the b-emitting 90Sr/90Y has an acute falloff of dose related to
the distance,19 the last 2 mm within the markers of the source
should be considered as having received a lower than pre-
scribed dose. In fact, the dose received at 1 mm from the
100% isodose is 86% of the prescribed dose, and at 2 mm,
60% of the prescribed dose (inner part of the gold marker). At
3 mm, the dose is 30% of the prescribed dose; at 4 mm, 13%
of the prescribed dose; and at 5 mm, 5% of the prescribed
dose. We defined the IRS as the segment encompassed by the
2 gold markers, which included the last 2 mm within the
markers with a lower than prescribed dose (up to 60% of
the prescribed dose). By this definition, late loss and reste-
nosis rate were significantly lower than those of the injured
edges (analyzed from the inner part of the gold marker).
Furthermore, the 5 cases of restenosis within the IRS were
located at the site of the initial MLD. These results may
reflect the fact that the dose at these last seeds of the source
was high enough to avoid the edge effect after the edges had
probably been injured during the procedure, especially when
a 20-mm-long balloon was used. Thus, the region receiving a
low dose may be defined, for this system and source, as the
5-mm-long segment located 2 mm farther from the 100%
isodose boundary, that is, beyond the inner part of the gold
marker. In this regard, we believe that the injury should be
completely restricted to the segment of the 100% isodose
curve of the radiation source (26 mm) and that the last 2 mm
at both extremities of the source and within the gold markers
may be considered relatively but probably not completely
safe. Finally, any injured segment covered by or beyond the
gold marker (up to 5 mm) must be considered to be at high
risk of failure at follow-up.
From the perspective of these findings and future technical
developments in the field, the following recommendations are
advisable. Filming every single balloon inflation performed
during the procedure would allow one to define the injured
area. More than ever, tenacious attention to detail in position-
ing the radiation catheter encompassing the entire injured
area must be mandatory. The development of longer sources
(.30 mm) would allow one to treat diffuse lesions and
completely cover those areas in which an extension of the
treatment was indicated because of procedural complications.
Equally, the use of online QCA in the decision-making would
avoid appreciation errors due to visual assessment of the
target area and subsequent underestimation or overestimation
of balloon lengths. Finally, the selection of the most suitable
fluoroscopic projections (eg, less foreshortening, no overlap-
ping) would avoid errors in the quantification of the region of
interest.
The facts that the locations of most of the restenoses were
in geographic miss edges and that late loss in those areas was
unexpectedly high must raise an alarm about the deleterious
effect of the combination of injury and low-dose radiation.
This hypothesis may be supported by the fact that the late loss
observed in those injured edges is higher than that reported in
recent clinical trials after either BA or stent implantation20,21
and higher than that demonstrated in the uninjured edges.
Balloon overstretch injury has been used as an experimental
model to study the restenosis process.8–10 The response of the
vessel wall to injury involves both neointimal hyperplasia8,9
and vessel remodeling.10,22,23 The stimulatory effect of low-
dose radiation after BA on smooth muscle cell proliferation
has been reported previously.11 In the low-dose radiation
group of this swine model (10 Gy), neointima was composed
of smooth muscle cells, with a marked increase in inflamma-
tory cells and less medial and intimal fibrosis than in the
higher-dose groups (15 and 20 Gy) and the control group. It
was suggested that at low dose, inadequate fibrosis was
induced to prevent effective smooth muscle cell migration
and to act as a diffuse barrier for mediators of chemotaxis,
chemokinesis, and cellular proliferation.11 Similarly, after
low-activity radioactive stent implantation (1 mCi) in a
porcine model, neointimal hyperplasia was significantly
greater than that after nonradioactive control stents.12 If
ongoing intravascular studies reveal that edge restenosis is
mainly due to plaque increase, the former hypothesis that at a
low dose, inadequate medial and intimal fibrosis to avoid
migration and proliferation predominates may become a
plausible explanation. Conversely, if negative remodeling is
the main contributor to the lumen loss, the excess of inflam-
matory cells demonstrated at low dose may be responsible for
subsequent adventitial fibrosis and vessel shrinkage. The
development of the so-called “candy wrapper” after radioac-
tive stent implantation5 may represent the clinical paradigm
of the combined deleterious effect of low-dose radiation and
injury. The latter is secondary to the angioplasty balloon used
for predilatation and postdilatation of the radioactive stent. In
this regard, a higher balloon-to-artery ratio was associated
with the presence of this phenomenon.5
Future trials must address the benefit of new technical
developments in the field (use of square deployment bal-
loons; hot-end, cold-end stents6; longer sources with smaller
radiation delivery catheters) to minimize the impact of injury
at the edges after either radioactive stent– or catheter-based
systems.
Figure 2. Difference in late loss between IRS, geographic miss
edges, and uninjured edges. De novo lesions and in-stent reste-
nosis demonstrated same degree of late loss between 3 groups.
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Study Limitations
In this study, only 1 type of radiation delivery catheter using
the b-source 90Sr/90Y was evaluated. Thus, the effect of either
other catheter-based systems using centering balloons and
different sources or the g-radiotherapy on the geographic
miss edges cannot be extrapolated from our results.
The actual dose at the margins of the radiation source has
not been calculated. A low dose at these edges was assumed
because the isotope 90Sr/90Y demonstrates an acute falloff
related to the distance from the 100% isodose boundary.19
This angiographic study was aimed at defining the concept
and the clinical implications of the geographic miss. To
define the mechanism of the unexpectedly high late loss and
the correlation between radiation dose and plaque extent at
the margins of the IRS, intravascular ultrasound studies must
be carried out.
The location of the segment receiving a low dose may vary
between systems and sources. Thus, the confidence margin to
be taken may vary accordingly.
The position of the source relative to the various balloon
inflations was assessed by comparing still frames at the same
part of the cardiac cycle from cineangiograms performed in
the same projections. However, small inaccuracies in the
definition of the IRS and the edges, derived from the axial
movement of the radiation source during the cardiac cycle,
cannot be completely ruled out.
This study was not placebo-controlled. Thus, the effect of
the sham source on the balloon-injured coronary segments
has not been determined.
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